Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up – Should You Buy?

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) gapped up before the market opened on Tuesday. The stock had previously closed at $11.00, but opened at $12.10. Ambu A/S shares last traded at $12.10, with a volume of 438 shares trading hands.

Wall Street Analyst Weigh In

Separately, UBS Group lowered shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat, Ambu A/S currently has a consensus rating of “Hold”.

Ambu A/S Trading Up 12.4%

The company’s 50 day moving average is $11.10 and its two-hundred day moving average is $10.99. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.77 and a quick ratio of 1.69. The firm has a market cap of $3.20 billion, a P/E ratio of 45.33 and a beta of 0.86.

Ambu A/S (OTCMKTS:AMBBY) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.14 earnings per share (EPS) for the quarter. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.